121 related articles for article (PubMed ID: 38428412)
1. Cellular senescence impact on immune cell fate and function.
Vicente R; Mausset-Bonnefont AL; Jorgensen C; Louis-Plence P; Brondello JM
Aging Cell; 2016 Jun; 15(3):400-6. PubMed ID: 26910559
[TBL] [Abstract][Full Text] [Related]
2. Aging and cancer.
Montégut L; López-Otín C; Kroemer G
Mol Cancer; 2024 May; 23(1):106. PubMed ID: 38760832
[TBL] [Abstract][Full Text] [Related]
3. Senescent cells: Living or dying is a matter of NK cells.
Antonangeli F; Zingoni A; Soriani A; Santoni A
J Leukoc Biol; 2019 Jun; 105(6):1275-1283. PubMed ID: 30811627
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells.
Colucci M; Zumerle S; Bressan S; Gianfanti F; Troiani M; Valdata A; D'Ambrosio M; Pasquini E; Varesi A; Cogo F; Mosole S; Dongilli C; Desbats MA; Contu L; Revankdar A; Chen J; Kalathur M; Perciato ML; Basilotta R; Endre L; Schauer S; Othman A; Guccini I; Saponaro M; Maraccani L; Bancaro N; Lai P; Liu L; Pernigoni N; Mele F; Merler S; Trotman LC; Guarda G; Calì B; Montopoli M; Alimonti A
Cancer Cell; 2024 Apr; 42(4):646-661.e9. PubMed ID: 38428412
[TBL] [Abstract][Full Text] [Related]
5. Unleashing a safe and potent pro-senescence anti-tumor strategy.
Chen S; Sun B; Dong Z
Cancer Cell; 2024 Apr; 42(4):504-507. PubMed ID: 38428411
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapeutic HCW9218 augments anti-tumor activity of chemotherapy via NK cell-mediated reduction of therapy-induced senescent cells.
Chaturvedi P; George V; Shrestha N; Wang M; Dee MJ; Zhu X; Liu B; Egan J; D'Eramo F; Spanoudis C; Gallo V; Echeverri C; You L; Kong L; Fang B; Jeng EK; Rhode PR; Wong HC
Mol Ther; 2022 Mar; 30(3):1171-1187. PubMed ID: 35051615
[TBL] [Abstract][Full Text] [Related]
7. Tumor Secretome to Adoptive Cellular Immunotherapy: Reduce Me Before I Make You My Partner.
Etxebeste-Mitxeltorena M; Del Rincón-Loza I; Martín-Antonio B
Front Immunol; 2021; 12():717850. PubMed ID: 34447383
[TBL] [Abstract][Full Text] [Related]
8. Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer Metastasis.
Guccini I; Revandkar A; D'Ambrosio M; Colucci M; Pasquini E; Mosole S; Troiani M; Brina D; Sheibani-Tezerji R; Elia AR; Rinaldi A; Pernigoni N; Rüschoff JH; Dettwiler S; De Marzo AM; Antonarakis ES; Borrelli C; Moor AE; Garcia-Escudero R; Alajati A; Attanasio G; Losa M; Moch H; Wild P; Egger G; Alimonti A
Cancer Cell; 2021 Jan; 39(1):68-82.e9. PubMed ID: 33186519
[TBL] [Abstract][Full Text] [Related]
9. The senescence-associated secretory phenotype (SASP) from mesenchymal stromal cells impairs growth of immortalized prostate cells but has no effect on metastatic prostatic cancer cells.
Alessio N; Aprile D; Squillaro T; Di Bernardo G; Finicelli M; Melone MA; Peluso G; Galderisi U
Aging (Albany NY); 2019 Aug; 11(15):5817-5828. PubMed ID: 31412320
[TBL] [Abstract][Full Text] [Related]
10. The Use of Retinoids for the Prevention and Treatment of Skin Cancers: An Updated Review.
Ramchatesingh B; Martínez Villarreal A; Arcuri D; Lagacé F; Setah SA; Touma F; Al-Badarin F; Litvinov IV
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293471
[TBL] [Abstract][Full Text] [Related]
11. Senescence-associated secretory phenotype and its impact on oral immune homeostasis.
Yue Z; Nie L; Zhao P; Ji N; Liao G; Wang Q
Front Immunol; 2022; 13():1019313. PubMed ID: 36275775
[TBL] [Abstract][Full Text] [Related]
12. Current Progress of CAR-NK Therapy in Cancer Treatment.
Pang Z; Wang Z; Li F; Feng C; Mu X
Cancers (Basel); 2022 Sep; 14(17):. PubMed ID: 36077853
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid receptor structures: the journey from single domains to full-length complex.
Rastinejad F
J Mol Endocrinol; 2022 Nov; 69(4):T25-T36. PubMed ID: 36069789
[TBL] [Abstract][Full Text] [Related]
14. Harnessing IL-15 signaling to potentiate NK cell-mediated cancer immunotherapy.
Ma S; Caligiuri MA; Yu J
Trends Immunol; 2022 Oct; 43(10):833-847. PubMed ID: 36058806
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
